US 11603364
Acyl hydrazone derivative compounds for treating disease
granted A61PA61P25/00A61P31/00
Quick answer
US patent 11603364 (Acyl hydrazone derivative compounds for treating disease) held by Alterity Therapeutics Limited expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alterity Therapeutics Limited
- Grant date
- Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P25/00, A61P31/00, A61P35/00